Transfemoral transcatheter aortic valve implantation facilitated by intravascular ultrasound-guided shockwave lithotripsy

Transfemoral transcatheter aortic valve implantation facilitated by intravascular ultrasound-guided shockwave lithotripsy

Chiam P, Lim Y, Sivathasan C.

AsiaIntervention 2021; 7(2): 116-117

Background

An 80-year-old male with chronic kidney disease (creatinine 200 µmol/L) presented with symptomatic severe aortic stenosis. The computed tomographic scan showed peripheral artery disease (PAD) with a heavily calcified distal aorta, and severely calcified stenoses of the right and left common iliac arteries (CIA), measuring, 4.9 mm and 3.7 mm, respectively (Panel A, Panel B). Transcatheter aortic valve implantation (TAVI) was chosen due to his age and elevated surgical risk. As the patient declined non-femoral approaches, we proceeded with transfemoral TAVI with vessel preparation using Shockwave Intravascular Lithotripsy (IVL) (Shockwave Medical, Santa Clara, CA, USA). IVL enables treatment of calcified stenoses by sonic pressure waves. Both superficial and deep calcium are disrupted with minimal impact on healthy tissue, achieving calcified plaque modification and increasing vessel compliance and size.

The femoral arteries were punctured under ultrasound guidance. A preprocedural aortoiliac angiogram was not performed in order to minimise contrast load and reduce the risk of acute kidney injury. An intravascular ultrasound (IVUS) (OptiCross™ 18 catheter; Boston Scientific, Marlborough, MA, USA), performed to help guide the lithotripsy procedure, confirmed CIA stenoses with napkin-ring calcifications (Panel C – IVUS image of the right common iliac artery, Panel D – IVUS image of the left common iliac artery, yellow arrows denote vessel calcification, white arrow denotes soft plaque). As the non-diseased external iliac artery diameter was approximately 7 mm, a 7×60 mm Shockwave balloon was selected. This was advanced over a 0.014-inch wire to the right CIA and inflated to 4 atm (lithotripsy delivery pressure). Four cycles of 30 pulses each were delivered and then two cycles were delivered to the left CIA (Panel E, Panel F) Repeat IVUS showed calcified plaque fractures with luminal gain (Panel G – IVUS image of the right common iliac artery after IVL, Panel H – IVUS image of the left common iliac artery after IVL, yellow arrowheads denote calcium fractures).

Apart from mild to moderate resistance during insertion of the 14 Fr expandable sheath from the right femoral artery, a 23 mm SAPIEN 3 valve (Edwards Lifesciences, Irvine, CA, USA) crossed the calcified right CIA inside the sheath without much difficulty and was successfully implanted under Sentinel™ (Boston Scientific) cerebral protection. The completion angiography showed no iliofemoral dissection with good flow (Panel I), and the femoral arteriotomy was closed with the ProGlide® (Abbott Laboratories, Abbott Park, IL, USA) pre-closure technique. IVUS-guided IVL can be used to facilitate transfemoral TAVI in patients with calcified PAD and is likely safer than using non-compliant or cutting balloons to dilate severely calcified iliofemoral vessels.

Share:

More Posts

Diagram showing the components and placement of a Left Ventricular Assist Device (LVAD)

What Is an Artificial Heart Pump (LVAD) and Who Needs One?

For patients with advanced heart failure, medications alone may no longer be enough to help the heart pump blood effectively. A Left Ventricular Assist Device (LVAD), often referred to as an artificial heart pump, can help improve blood flow, relieve symptoms, and enhance quality of life. Learn how LVADs work, who may benefit from them, and what to expect before, during and after implantation.

Middle-aged Asian man clutching his chest, appearing to experience chest pain or symptoms of cardiac arrest.

Can Healthy Individuals Get Cardiac Arrest?

Even seemingly healthy individuals without known heart conditions can experience cardiac arrest. Recognising risk factors and adopting a heart-healthy lifestyle, including regular exercise, a balanced diet, avoiding smoking, limiting alcohol intake, managing stress and going for health screening regularly, can potentially reduce the risk.

Leaky tricuspid valve (tricuspid regurgitation) showing backward blood flow from the right ventricle into the right atrium

Minimally Invasive Treatment Options for Leaky Tricuspid Valve

A leaky tricuspid valve, also known as tricuspid regurgitation, is a heart valve condition that can cause swelling, breathlessness, fatigue, and worsening heart failure if left untreated. While open-heart surgery was once the only definitive treatment, advances in heart valve technology now allow selected patients to be treated using minimally invasive catheter-based procedures, including tricuspid transcatheter edge-to-edge repair, transcatheter tricuspid valve replacement, and caval valve implantation.

the connection between sleep problems and heart failure

The Hidden Connection between Sleep Problems and Heart Failure

Sleep problems are common among people with heart failure, and research shows the relationship goes both ways. Conditions such as obstructive sleep apnoea (OSA) and insomnia can worsen heart failure symptoms, while heart failure itself often leads to disturbed or poor-quality sleep. Recognising this two-way connection is an important step toward better symptom control and long-term heart health.

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy